NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Wednesday that its fourth quarter revenues rose 6 percent, largely due to a 13 percent uptick in its clinical labs segment driven by increased sales of its molecular diagnostics tests.

For the three months ended July 31, the company reported total revenues of $28.2 million, up from $26.6 million a year earlier.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.